MGRX vs. BNR, CCM, MRAI, ENZ, BRTX, SSY, OTRK, BGLC, ATIP, and VSEE
Should you be buying Mangoceuticals stock or one of its competitors? The main competitors of Mangoceuticals include Burning Rock Biotech (BNR), Concord Medical Services (CCM), Marpai (MRAI), Enzo Biochem (ENZ), BioRestorative Therapies (BRTX), SunLink Health Systems (SSY), Ontrak (OTRK), BioNexus Gene Lab (BGLC), ATI Physical Therapy (ATIP), and Vsee Health (VSEE). These companies are all part of the "healthcare" industry.
Mangoceuticals vs. Its Competitors
Burning Rock Biotech (NASDAQ:BNR) and Mangoceuticals (NASDAQ:MGRX) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, media sentiment, valuation, earnings, community ranking and profitability.
Burning Rock Biotech has a beta of 0.74, meaning that its stock price is 26% less volatile than the S&P 500. Comparatively, Mangoceuticals has a beta of 2.75, meaning that its stock price is 175% more volatile than the S&P 500.
30.0% of Burning Rock Biotech shares are held by institutional investors. Comparatively, 56.7% of Mangoceuticals shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by company insiders. Comparatively, 16.0% of Mangoceuticals shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
In the previous week, Mangoceuticals had 1 more articles in the media than Burning Rock Biotech. MarketBeat recorded 3 mentions for Mangoceuticals and 2 mentions for Burning Rock Biotech. Mangoceuticals' average media sentiment score of 0.79 beat Burning Rock Biotech's score of 0.11 indicating that Mangoceuticals is being referred to more favorably in the news media.
Burning Rock Biotech has a net margin of -83.50% compared to Mangoceuticals' net margin of -1,237.00%. Burning Rock Biotech's return on equity of -60.68% beat Mangoceuticals' return on equity.
Mangoceuticals has lower revenue, but higher earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Mangoceuticals, indicating that it is currently the more affordable of the two stocks.
Burning Rock Biotech received 5 more outperform votes than Mangoceuticals when rated by MarketBeat users.
Summary
Burning Rock Biotech and Mangoceuticals tied by winning 7 of the 14 factors compared between the two stocks.
Get Mangoceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for MGRX and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MGRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Mangoceuticals Competitors List
Related Companies and Tools
This page (NASDAQ:MGRX) was last updated on 6/13/2025 by MarketBeat.com Staff
